Subsidising the spread of COVID-19: Evidence from the UK’S Eat-Out-to-Help-Out Scheme*
Abstract. This paper documents that a large-scale government subsidy aimed at encouraging people to eat out in restaurants in the wake of the first 2020 COVID-1
Related Articles
Prevalence of Immunosuppression Among US Adults
This analysis presents population prevalence estimates of immunosuppression among US adults using data from the 2021 National Health Interview Survey.
Prevalence of Immunosuppression Among US Adults
This analysis presents population prevalence estimates of immunosuppression among US adults using data from the 2021 National Health Interview Survey.
Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19 | NEJM
Original Article from The New England Journal of Medicine — Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19
ATTCs call for action to assure the future of advance therapies adoption in the UK • ATTC Network – Advanced Therapy Treatment Centre
The future of access for patients to life changing advanced therapies lies in […]
Concordance between HokUS-10 Scoring and Transjugular Liver Biopsy for the Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Allogeneic Stem Cell Transplantation
The aim of this study was to evaluate the concordance between clinical diagnosis and pathologic findings of veno-occlusive disease/sinusoidal obstruct…
Cancers Attributable to Infections in the US in 2017
This meta-analysis estimates the percentage and number of incident cancers attributable to infections in the US among adults and children for the most recent year…
NICE Approves Glofitamab (Columvi) for Aggressive Lymphoma
NHS England to fast-track treatment access for patients with diffuse large B-cell lymphoma.
2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC)
Guidelines evaluate and summarize available evidence with the aim of assisting health professionals in proposing the best diagnostic or therapeutic approach for
The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial
In pediatric hematopoietic cell transplant (HCT) recipients, 2 doses of high-dose trivalent influenza vaccine were more immunogenic than 2 doses of standard-dos
